Mahoney Karen
Known title: Chief Human Resources OfficerCIK: 0002055280
Associated companies
Transaction History
| VCEL | ▲ Buy | Option Exercise | 2,625 | $0 | 7/22/2025 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 771 | $29K | 7/22/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,625 | $0 | 7/22/2025 | View on chart |
| VCEL | ▼ Sell | Tax Withholding | 771 | $29K | 7/22/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Truist lowers Vericel price target to $52
Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.
Truist lowers Vericel price target to $52. Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.